Erica B Feldman1, Raymond Balise1, Eugene Schiff1, Nicole Whitehead2, Emmanuel Thomas3,4. 1. University of Miami Miller School of Medicine, Miami, FL, USA. 2. University of Florida, Gainesville, FL, USA. 3. University of Miami Miller School of Medicine, Miami, FL, USA. ethomas1@med.miami.edu. 4. Schiff Center for Liver Disease, Sylvester Comprehensive Cancer Center, 1550 NW 10th Ave, Papanicolaou Bldg. Rm. PAP 514, Miami, FL, 33136, USA. ethomas1@med.miami.edu.
Abstract
METHODS: 357 patients at a free STD clinic in Miami, FL were screened for HCV. Surveys were administered assessing risk factors for infectious disease transmission, and HCV and HIV screening history. RESULTS: 15.1% of participants had been screened for HCV before whereas 83.8% had been screened for HIV (n = 356). Of the patients previously screened for HCV (n = 54), 98.2% of these patients had previously been screened for HIV as well. CONCLUSION: This data shows the low prevalence of prior HCV screenings in a high-risk population in Miami, FL. Participants who had previously received an HIV screening test were more likely to report receiving a prior HCV screening. Despite the high prevalence of HCV, most HCV infections are undiagnosed. Mortality from HIV has been declining in the United States while mortality from HCV is increasing. To decrease HCV related mortality, we recommend offering HCV screening in conjunction with HIV screening.
METHODS: 357 patients at a free STD clinic in Miami, FL were screened for HCV. Surveys were administered assessing risk factors for infectious disease transmission, and HCV and HIV screening history. RESULTS: 15.1% of participants had been screened for HCV before whereas 83.8% had been screened for HIV (n = 356). Of the patients previously screened for HCV (n = 54), 98.2% of these patients had previously been screened for HIV as well. CONCLUSION: This data shows the low prevalence of prior HCV screenings in a high-risk population in Miami, FL. Participants who had previously received an HIV screening test were more likely to report receiving a prior HCV screening. Despite the high prevalence of HCV, most HCV infections are undiagnosed. Mortality from HIV has been declining in the United States while mortality from HCV is increasing. To decrease HCV related mortality, we recommend offering HCV screening in conjunction with HIV screening.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Ivo Ditah; Badr Al Bawardy; Humberto C Gonzalez; Behnam Saberi; Callistus Ditah; Patrick S Kamath; Michael Charlton Journal: Am J Gastroenterol Date: 2015-03-10 Impact factor: 10.864
Authors: Kathleen N Ly; Jian Xing; R Monina Klevens; Ruth B Jiles; John W Ward; Scott D Holmberg Journal: Ann Intern Med Date: 2012-02-21 Impact factor: 25.391
Authors: William N Southern; Mari-Lynn Drainoni; Bryce D Smith; Elisa Koppelman; M Diane McKee; Cindy L Christiansen; Allen L Gifford; Cindy M Weinbaum; Alain H Litwin Journal: Qual Manag Health Care Date: 2014 Jan-Mar Impact factor: 0.926
Authors: Robert Heimer; Scott Clair; Lauretta E Grau; Ricky N Bluthenthal; Patricia A Marshall; Merrill Singer Journal: Addiction Date: 2002-10 Impact factor: 6.526
Authors: Brianna L Norton; Corrine I Voils; Sarah H Timberlake; Emily J Hecker; Neela D Goswami; Kim M Huffman; Anneka Landgraf; Susanna Naggie; Jason E Stout Journal: BMC Infect Dis Date: 2014-02-10 Impact factor: 3.090
Authors: Jemima A Frimpong; Thomas D'Aunno; David C Perlman; Shiela M Strauss; Alissa Mallow; Diana Hernandez; Bruce R Schackman; Daniel J Feaster; Lisa R Metsch Journal: Trials Date: 2016-03-03 Impact factor: 2.279
Authors: Alexandra DeBose-Scarlett; Raymond Balise; Deukwoo Kwon; Susan Vadaparampil; Steven Xi Chen; Eugene R Schiff; Gladys Patricia Ayala; Emmanuel Thomas Journal: J Transl Med Date: 2018-06-28 Impact factor: 5.531
Authors: Xinyi Jiang; Robert L Parker; Scott Martin Vouri; Weihsuan Lo-Ciganic; Vakaramoko Diaby; Linda Henry; Haesuk Park Journal: Am J Prev Med Date: 2021-06-29 Impact factor: 6.604